CIC
PYXS icon

Cornercap Investment Counsel’s Pyxis Oncology PYXS Stock Holding History

Cornercap Investment Counsel’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-74,903
Closed -$319K – 675
2024
Q1 		$319K Hold
74,903
– – 0.05% 512
2023
Q4 		$135K Hold
74,903
– – 0.02% 553
2023
Q3 		$149K Sell
74,903
-1,002
-1% -$2.32K 0.03% 515
2023
Q2 		$194K Buy
+75,905
New +$241K 0.03% 517

Other funds holding PYXS

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cornercap Investment Counsel's PYXS Position: Q2 2024 in Review

Cornercap Investment Counsel sold out of Pyxis Oncology (PYXS) in Q2 2024, closing a stake of 74,903 shares — an estimated $319K sold.

Cornercap Investment Counsel first reported a position in PYXS in Q2 2023 and held it in 4 quarters. The position peaked at $319K in Q1 2024. 80 funds tracked by Wall St. Rank hold PYXS as of Q2 2024.

  • Cornercap Investment Counsel reported no remaining Pyxis Oncology position as of Q2 2024 after selling out during the quarter.
  • Cornercap Investment Counsel sold 74,903 Pyxis Oncology shares in Q2 2024, an estimated $319K.
  • Cornercap Investment Counsel first reported a position in Pyxis Oncology in Q2 2023 and held it in 4 quarters.
  • Cornercap Investment Counsel's Pyxis Oncology position peaked at $319K in Q1 2024.
  • 80 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2024.

Based on Cornercap Investment Counsel's 13F filing for Q2 2024, filed 8 Aug 2024.